Charles Eby

Use of Pharmacogenetic and Clinical Factors to Predict the Therapeutic Dose of Warfarin

Charles Eby, JA Johnson, Elena Deych et al. · Clinical Pharmacology & Therapeutics · 2008 · 834 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +13

CYP4F2 genetic variant alters required warfarin dose

Michael D. Caldwell, Tarif Awad, Julie A. Johnson et al. · Blood · 2008 · 522 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +11

Use of pharmacogenetics and clinical factors to predict the maintenance dose of warfarin

Charles Eby, Paul E. Milligan, Gerald A. Banet et al. · Thrombosis and Haemostasis · 2003 · 323 citations

Veterinary Medicine, Pharmacology, Medical Genetics +12

Venous Thromboembolic Disease

Michael B. Streiff, Paula Bockenstedt, Spero R. Cataland et al. · Journal of the National Comprehensive Cancer Network · 2011 · 236 citations · Full text

Medicine, Hematology, Oncology +17

Cancer-Associated Venous Thromboembolic Disease, Version 1.2015

Michael B. Streiff, Bjorn Holmstrom, Aneel A. Ashrani et al. · Journal of the National Comprehensive Cancer Network · 2015 · 216 citations

Medicine, Oncology, Pharmacotherapy +17